References
Arena S, Barbieri F, Thellung S, Pirani P, Corsaro A, Villa V, Dadati P, Dorcaratto A, Lapertosa G, Ravetti JL, Spaziante R, Schettini G, Florio T (2004) Expression of somatostatin receptor mRNA in human meningiomas and their implication in vitro antiproliferative activity. J Neurooncol 66:155–166
Agaimy A, Buslei R, Coras R, Rubin BP, Mentzel T (2014) Comparative study of soft tissue perineurioma and meningioma using a five-marker immunohistochemical panel. Histopathology 65:60–70
Körner M, Waser B, Schonbrunn A, Perren A, Reubi JC (2012) Somatostatin receptor subtype 2A immunohistochemistry using a new monoclonal antibody selects tumors suitable for in vivo somatostatin receptor targeting. Am J Surg Pathol 36:242–252
Lusis EA, Chicoine MR, Perry A (2005) High throughput screening of meningioma biomarkers using a tissue microarray. J Neurooncol 73:219–223
Reubi JC, Maurer R, Klijn JG, Stefanko SZ, Foekens JA, Blaauw G, Blankenstein MA, Lamberts SW (1986) High incidence of somatostatin receptors in human meningiomas: biochemical characterization. J Clin Endocrinol Metab 63:433–438
Reubi JC, Schaer JC, Waser B, Mengod G (1994) Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res 54:3455–3459
Schnitt SJ, Vogel H (1986) Meningiomas. Diagnostic value of immunoperoxidase staining for epithelial membrane antigen. Am J Surg Pathol 10:640–649
Schulz S, Pauli SU, Schulz S, Händel M, Dietzmann K, Firsching R, Höllt V (2000) Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A. Clin Cancer Res 6:1865–1874
Xu XX, Zhang LH, Xie X (2014) Somatostatin receptor type 2 contributes to the self-renewal of murine embryonic stem cells. Acta Pharmacol Sin 35:1023–1030
Acknowledgments
The authors would like to thank Ms. Kim Thompson, who performed the immunohistochemistry studies at PhenoPath, and Dr. Abul Abbas, Chair of the Department of Pathology at University of California San Francisco, who funded this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Menke, J.R., Raleigh, D.R., Gown, A.M. et al. Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen. Acta Neuropathol 130, 441–443 (2015). https://doi.org/10.1007/s00401-015-1459-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-015-1459-3